Participants were randomly assigned to BCDTC or traditional adjudication.
Over 20% of the sample died, largely due to substance use-related causes.
15-year mortality rates did not differ between BCDTC and traditional adjudication.
During the intervention, most participants did not receive MAT.
Drug courts should implement best practices, including MAT and naloxone training.
The Impact of Drug Court Participation on Mortality
August 13, 2019 | By Communications
Share this article